Delivery Order SPE2DR25D3111-SPE2DR26FF3LY
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $37,925.20 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a $2,953.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,133.43 to supply Rotarix vaccine in oral syringe format (1.5ML) with a completion date of October 31, 2025. This is a firm fixed price delivery order issued on October 30, 2025, with no set-aside designation, indicating the award was made through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.92 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5ml) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $7,507.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Rotarix vaccine in oral syringe format (1.5mL units). The contract, which is scheduled for completion by December 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,008.90 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5ml) on November 14, 2025, with a completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a $31,634 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on September 29, 2025, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,383.30 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3LYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,486.37 to AmerisourceBergen Drug Corp for Rotarix Vaccine oral syringes (1.5 mL) on December 4, 2025, with an ultimate completion date of December 5, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and associated medical commodities. The company's extensive federal contract portfolio demonstrates its capability to meet Defense Health Agency and other government healthcare system requirements across multiple therapeutic domains through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/3/25 |